Results 231 to 240 of about 644,703 (404)

Low‐dose cannabidiol increases plasma concentrations of amitriptyline: A clinical drug–drug interaction study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Abstract Aims Cannabidiol (CBD), the main non‐intoxicating compound from the cannabis plant, is regularly used by patients with chronic pain who also take analgesics. CBD has previously been shown to inhibit CYP‐mediated drug metabolism. This study aimed to characterize the potential pharmacokinetic interaction of CBD with amitriptyline and tramadol ...
Andriy A. Gorbenko   +9 more
wiley   +1 more source

Comparing the Analgesic and Anti-Ulcer Properties of Green Tea Aqueous Extract with Licofelone [PDF]

open access: hybrid
Habibeh Mashayekhi‐Sardoo   +3 more
openalex   +1 more source

Long-term analgesic use after low-risk surgery: a retrospective cohort study.

open access: yesArchives of Internal Medicine, 2012
A. Alam   +5 more
semanticscholar   +1 more source

Clinical pharmacology and prescribing education: An updated medical school curriculum from the British Pharmacological Society

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Prescribing is a complex, essential skill that doctors must acquire to practice medicine safely and effectively. The British Pharmacological Society has historically provided a core curriculum to guide clinical pharmacology and prescribing education in UK medical schools.
Dagan O. Lonsdale   +5 more
wiley   +1 more source

Analgesic efficacy of hydromorphone in American alligators (Alligator mississippiensis) [PDF]

open access: gold
Scott E. Henke   +5 more
openalex   +1 more source

Neo‐kyotorphin (Thr—Ser—Lys—Tyr—Arg), a new analgesic peptide [PDF]

open access: bronze, 1983
Yoshiaki Kiso   +6 more
openalex   +1 more source

Pharmacokinetics of dolutegravir, tenofovir and lamivudine during venous–venous extracorporeal membrane oxygenation (VV‐ECMO): A case report

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
While providing potentially life‐saving cardiorespiratory support for critically ill patients, extracorporeal membrane oxygenation (ECMO) may detrimentally affect pharmacokinetic (PK) performance and concurrent drug efficacy and safety. We describe a patient with Pneumocystis jirovecii pneumonia (PJP) in the context of acquired immunodeficiency ...
Tom C. Zwart   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy